Study supports allergy vaccine using genetically engineered pollen

08/10/2004 | Forbes

Researchers report the first-ever trial on an allergy vaccine developed from genetically engineered pollen shows promise in treating the condition by triggering a strong immune response in the body. The vaccine is seen as a replacement for immunotherapy, a common treatment for allergies that sometimes can make the problem worse.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY